Expression of these genes was markedly suppressed in the GVHD recipients receiving Ifng–/– T cells, as were those involved in JAK/STAT, NF-κB, and TNF signaling pathways (Figure 6, B and C, and Supplemental Figure 6C). The gene discussed is IFNG; the disease is graft versus host disease.